These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 27081693)
1. Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis. Wang H; Ma JL; Yang YG; Song Y; Wu J; Qin YY; Zhao XL; Wang J; Zou LL; Wu JF; Li JM; Liu CB Oncotarget; 2016 Aug; 7(31):49075-49090. PubMed ID: 27081693 [TBL] [Abstract][Full Text] [Related]
2. Novel peptide MT23 for potent penetrating and selective targeting in mouse melanoma cancer cells. Zhou N; Wu J; Qin YY; Zhao XL; Ding Y; Sun LS; He T; Huang XW; Liu CB; Wang H Eur J Pharm Biopharm; 2017 Nov; 120():80-88. PubMed ID: 28860066 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier. Young Kim H; Young Yum S; Jang G; Ahn DR Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides. Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448 [TBL] [Abstract][Full Text] [Related]
5. Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine. Lee SA; Kim BR; Kim BK; Kim DW; Shon WJ; Lee NR; Inn KS; Kim BJ Biomaterials; 2013 Oct; 34(30):7495-505. PubMed ID: 23827187 [TBL] [Abstract][Full Text] [Related]
6. [Cell membrane-penetrating capacity of hPP10-Cu, Zn-SOD fusion protein and its antioxidant and anti-inflammatory activity]. Zhang J; Yao J; Yang Y; Wang F; Zheng Q; Li X; Liu C Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1059-1069. PubMed ID: 38977335 [TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery of nucleic acid by cell-permeable hPP10 peptide. Ding Y; Zhao X; Geng J; Guo X; Ma J; Wang H; Liu C J Cell Physiol; 2019 Jul; 234(7):11670-11678. PubMed ID: 30515802 [TBL] [Abstract][Full Text] [Related]
8. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide. Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers. Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361 [TBL] [Abstract][Full Text] [Related]
10. Cell penetration: scope and limitations by the application of cell-penetrating peptides. Reissmann S J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216 [TBL] [Abstract][Full Text] [Related]
11. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. Kardani K; Bolhassani A PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823 [TBL] [Abstract][Full Text] [Related]
12. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery. Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168 [TBL] [Abstract][Full Text] [Related]
13. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action. Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593 [TBL] [Abstract][Full Text] [Related]
14. Intelligent substance delivery into cells using cell-penetrating peptides. Tashima T Bioorg Med Chem Lett; 2017 Jan; 27(2):121-130. PubMed ID: 27956345 [TBL] [Abstract][Full Text] [Related]
15. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics. Lönn P; Kacsinta AD; Cui XS; Hamil AS; Kaulich M; Gogoi K; Dowdy SF Sci Rep; 2016 Sep; 6():32301. PubMed ID: 27604151 [TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo. Skotland T; Iversen TG; Torgersen ML; Sandvig K Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056 [TBL] [Abstract][Full Text] [Related]
17. Cellular uptake and in vivo distribution of polyhistidine peptides. Iwasaki T; Tokuda Y; Kotake A; Okada H; Takeda S; Kawano T; Nakayama Y J Control Release; 2015 Jul; 210():115-24. PubMed ID: 25980622 [TBL] [Abstract][Full Text] [Related]
18. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide. Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. Wang H; Zhong CY; Wu JF; Huang YB; Liu CB J Control Release; 2010 Apr; 143(1):64-70. PubMed ID: 20025914 [TBL] [Abstract][Full Text] [Related]